Pfizer doubles its web sales in China

 30-Mar-16, Internet Retailer

Online shoppers in China are steadily increasing their purchases of health products, and that offers an opportunity for popular U.S. brands of nutrition supplements. E-commerce sales of Pfizer Inc.’s health products, including popular supplements like Caltrate and Centrum, are growing at a more than 100% every year in China.

Image: Alizila

In fact, China has become Pfizer’s second-largest market for health products, exceeded only by the U.S. More than 200 million Chinese consumers have purchased health products from Pfizer.

Pfizer has been selling since 2012 through an official storefront Tmall in 2012, one of the two giant online shopping portals operated by China’s leading e-commerce company, Alibaba Group Holding Ltd. Pfizer also sells on JD.com, Alibaba’s leading competitor, and other marketplaces in China, including Yhd.com, which is owned by Wal-Mart Stores Inc.

 Read the full article 

 Insights